
Young Investigator Award
Established in 1983, the prestigious Young Investigator Award honors the early achievements of scientists and physician-scientists engaged in discovery-based research focused on diseases and development in children. This award recognizes a rising star whose outstanding scientific research accomplishments help to unravel the mysteries of childhood development or disease.
Submission Timeline: August 15 – September 30
Award

Eligibility Criteria
Nomination Requirements
Curriculum Vitae of Nominee
Manuscript of Research Work
Nominator’s Letter of Support
Senior Investigator Letter of Support (if different from nominator)
Three to Five Additional Letters of Support
Selection Process
Current Recipient
Dr. Emily Heikamp is a physician-scientist and pediatric oncologist at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Her laboratory focuses on an aggressive subtype of pediatric acute myeloid leukemia (AML) driven by chromosomal rearrangements of the Nucleoporin 98 (NUP98) gene. She discovered that these leukemias require the Menin-KMT2A chromatin complex for survival and demonstrated that pharmacologic disruption of this interaction induces terminal differentiation of malignant cells.

Emily Heikamp, MD, PhD
Harvard Medical School
